Associate Director, Patient Engagement; Engagement & Diversity Delivery at Eli Lilly and Company

Indianapolis, Indiana, United States

Apply Now

Not SpecifiedCompensation

Senior (5 to 8 years), Expert & Leadership (9+ years)Experience Level

Full TimeJob Type

UnknownVisa

Healthcare, PharmaceuticalsIndustries

Requirements

Bachelor's degree in a scientific or health-related field, marketing (or equivalent degree)
Minimum 5 years experience in clinical trials/drug development or broader pharmaceutical industry
Legally authorized to be employed in the United States (no sponsorship anticipated)
Post-graduate degree (e.g., PharmD, M.S., M.B.A., Ph.D.) preferred

Responsibilities

Identify innovative vendors and third parties to deliver recruitment and retention strategies that reach and engage representative patient populations
Optimize vendor services for value to meet recruitment, diversity, and retention goals
Collaborate with Patient Engagement colleagues to optimize strategy delivery, including content generation, vendor performance, best practices, and customer concerns
Oversee financial aspects of strategy delivery and adjust capabilities as needed
Collaborate within the Clinical Capabilities team and across the organization (e.g., Clinical Design Delivery and Analytics) to share best practices, drive efficiency, and influence strategic delivery
Ensure a culture of quality, inspection readiness, and prompt delivery of assets
Operationalize clinical trial recruitment and retention strategies for diverse populations across therapeutic areas, including informed decision-making and budget oversight
Drive execution of clinical trial strategies through goal setting, innovative approaches, and regulatory submissions
Collaborate with Clinical Capabilities and CDDA to create, implement, and measure diversity strategies
Apply community-based research to increase trial access for representative populations
Partner with Engagement & Diversity Capabilities to identify and manage innovative vendors and establish key performance indicators
Ensure creation of culturally sensitive, health-literate deliverables to optimize recruitment and retention
Maintain and expand relationships with internal and external stakeholders to boost enrollment and retention
Ensure compliance with global regulations
Drive continuous learning and improvement by addressing patient, caregiver, and investigator needs and implementing internal changes
Lead and influence cross-functional communication and shared learning
Drive adoption of innovative approaches for recruitment and retention of diverse populations, proactively mitigating issues
Leverage data trends to improve future studies from engagement through retention
Engage external vendors to maintain a competitive edge in recruitment and retention
Collaborate with industry representatives to learn and apply key findings, shaping environmental practices
Foster a culture of partnership and shared learning to standardize efficient practices
Support integration of cultural understanding into clinical program strategies

Skills

Patient Engagement

Recruitment Strategies

Retention Strategies

Diversity Delivery

Vendor Management

Budget Oversight

Clinical Trials

Regulatory Submissions

Strategic Delivery

Quality Management

Inspection Readiness

Eli Lilly and Company

Develops and delivers prescription medicines globally

About Eli Lilly and Company

Eli Lilly and Company is a global pharmaceutical company that focuses on discovering, developing, and delivering medicines to improve health. The company has a long history of scientific achievements, including the creation of insulin, the first life-saving treatment for diabetes. Lilly's operations involve extensive research and development to create new medications and enhance existing ones, ensuring they are safe and effective. Their products are primarily prescription medicines sold to healthcare providers for various medical conditions, including diabetes, cancer, and pain management. What sets Lilly apart from its competitors is its strong commitment to ethical practices and the protection of its products from counterfeiting. The company's goal is to enhance lives through innovative medical solutions while maintaining high standards of quality and ethics.

Indianapolis, IndianaHeadquarters

1876Year Founded

$1,180.1MTotal Funding

IPOCompany Stage

Biotechnology, HealthcareIndustries

10,001+Employees

Risks

Competition from Novo Nordisk's Ozempic may impact tirzepatide's market share.

Potential construction delays in Indiana could affect GLP-1 drug production timelines.

Regulatory challenges may hinder Kisunla's expansion in new Alzheimer's markets.

Differentiation

Eli Lilly's rich history includes the first life-saving insulin treatment.

Lilly's strategic partnerships enhance its position in neurodegenerative disease treatments.

FDA approval of Zepbound opens new therapeutic markets for sleep disorder treatments.

Upsides

Lilly's $9 billion complex in Indiana boosts GLP-1 drug production capacity.

Kisunla's approval in China expands Lilly's Alzheimer's treatment market in Asia.

Collaboration with EVA Pharma enhances Lilly's reputation as socially responsible.

Land your dream remote job 3x faster with AI

Try Jobo Free